The Patent Finder

Maintenance fees coming due

Bioverativ Therapeutics Inc.

18 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Dec 9, 2026. Unpaid by Jun 9, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 9,050,318Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
In force
Fee due Dec 9, 2026
Lapses if unpaid Jun 9, 2027
 · High confidence
Bioverativ Therapeutics Inc.In forceDec 9, 2026Jun 9, 2027High confidence
US 11,685,771Recombinant Factor VIII Proteins
In force
Fee due Dec 27, 2026
Lapses if unpaid Jun 28, 2027
 · High confidence
Bioverativ Therapeutics Inc.In forceDec 27, 2026Jun 28, 2027High confidence
US 10,370,430Recombinant Factor VIII Proteins
In force
Fee due Feb 6, 2027
Lapses if unpaid Aug 6, 2027
 · High confidence
Bioverativ Therapeutics Inc.In forceFeb 6, 2027Aug 6, 2027High confidence
US 10,370,431Optimized Factor VIII Gene
In force
Fee due Feb 6, 2027
Lapses if unpaid Aug 6, 2027
 · High confidence
Bioverativ Therapeutics Inc.In forceFeb 6, 2027Aug 6, 2027High confidence
US 10,391,152Methods of Using a Fixed Dose of a Clotting Factor
In force
Fee due Feb 27, 2027
Lapses if unpaid Aug 27, 2027
 · High confidence
Bioverativ Therapeutics Inc.In forceFeb 27, 2027Aug 27, 2027High confidence
US 11,747,351Assays to Monitor Bleeding Disorders
In force
Fee due Mar 5, 2027
Lapses if unpaid Sep 7, 2027
 · High confidence
Bioverativ Therapeutics Inc.In forceMar 5, 2027Sep 7, 2027High confidence
US 11,753,461Optimized Factor VIII Genes
In force
Fee due Mar 12, 2027
Lapses if unpaid Sep 13, 2027
 · High confidence
Bioverativ Therapeutics Inc.In forceMar 12, 2027Sep 13, 2027High confidence
US 10,421,798Factor VIII Compositions and Methods of Making and Using Same
In force
Fee due Mar 24, 2027
Lapses if unpaid Sep 24, 2027
 · High confidence
Bioverativ Therapeutics Inc.In forceMar 24, 2027Sep 24, 2027High confidence
US 11,787,851Optimized Factor VIII Gene
In force
Fee due Apr 17, 2027
Lapses if unpaid Oct 18, 2027
 · Medium confidence
Bioverativ Therapeutics Inc.In forceApr 17, 2027Oct 18, 2027Medium confidence
US 9,233,145Factor IX Polypeptides and Methods of Use Thereof
In force
Fee due Jul 12, 2027
Lapses if unpaid Jan 12, 2028
 · Medium confidence
Bioverativ Therapeutics Inc.In forceJul 12, 2027Jan 12, 2028Medium confidence
8 more maintenance fees coming due in the 12 months from Nov 21, 2026 · Pro
10 of 18 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited